Introduction

Due to the high prevalence of dementia, problems of treatment, patients’ independence and need for care, treating older patients represents a growing challenge for health systems and social care [1]. There is a notion that the most common causes of dementia, Alzheimer’s disease (AD) and vascular dementia (VD), sit on different parts of the spectrum of a single syndrome, where vascular risk factors play a vital role [2, 3]. Blood platelets show similarities to neurons, and previous studies have identified changes in their activity, both in dementia and in many cardiovascular conditions [4, 5]. It is known that blood platelets, like neurons, can metabolize serotonin, amyloid precursor protein and amyloid-beta derivative [6,7,8]. The changes in platelet activity occurring in old age include lower stimulation thresholds of platelet aggregation, a decrease in the number of plasma membrane receptors for platelet prostacyclin and an increase in the production of fibrinogen activator inhibitor by platelets. All those modifications promote prothrombotic and proinflammatory states [9]. Previous studies indicate that altered platelet activity may occur in response to increased serum concentration of interleukin 6, secreted primarily by monocytes and macrophages [10, 11]. Platelet activity can be assessed by simple platelet parameters such as platelet count (PLT), mean platelet volume (MPV) and platelet distribution width (PDW) routinely obtained during analysis of peripheral blood morphology [12,13,14]. Recent studies showed contradictory results concerning the relationship between MPV and cognitive performance [15,16,17,18,19]. Therefore, the aim of the study was to evaluate the relationship between basic platelet indices (PI) and the cognitive and functional performance of older patients admitted to the hospital ward.

Methods

Participants

The cross-sectional study initially included 1237 patients, aged ≥ 60 years old, hospitalized in the acute care Geriatric University Clinic, Lodz Central Veterans’ Hospital (Poland), during a 2-year period. The inclusion criteria comprised the presence of a complete blood count including blood platelet indices, and conducted cognitive and physical ability assessment. The criteria for the participation in this study were also efficient verbal communication and consent given for the participation. Out of the 1237 hospitalization cases, 483 were excluded from the study due to repetitive measurements or incomplete data, usually because of severe dementia or terminal illness. As a result, 754 patients, all of them Caucasian (218 men and 536 women), were included in the study. Of those 754 subjects, 242 were with dementia of various etiologies but were able to complete the questionnaires and were therefore included in the study. The diagnosis of dementia was established based on previous medical records and anamnesis provided by patients’ caregivers.

Also, on the basis of an accurate interview with the patient and/or caregiver and a review of previous medical records, we analysed the participants’ medical history including a range of pathological conditions that were active in the pre-hospital admission period: hypertension, diabetes, congestive heart disease, ischemic heart disease, atrial fibrillation, previous myocardial infarction or stroke, hypercholesterolemia, chronic pulmonary diseases, osteoporosis, osteoarthrosis, dementia and depression. Anthropometric measurements including body mass and height were obtained. Body mass index (BMI) was calculated as body mass in kilograms divided by the height in metres squared.

The assessment of global cognitive function and functional ability was performed by qualified physicians using the Mini-Mental State Examination (MMSE), the seven-point Clock Drawing Test (CDT), the Katz Index of Independence in Activities of Daily Living (ADL), the Lawton Instrumental Activities of Daily Living Scale (IADL) and the Vulnerable Elders Survey (VES-13) questionnaire [20,21,22,23,24].

The study was approved by the Ethics Committee of the Medical University of Lodz and written informed consent was obtained from the participants.

Blood collection and haematological measurements

The haematology values used in the study were obtained from the first blood collection, taken from participants in the morning after a minimum 8 h of fasting. Blood samples were obtained by venipuncture in a volume of 3 mL using blood tubes (K3EDTA) and the Vacutainer BD system and were sent to laboratory directly after collection. Blood samples were delivered to the hospital’s central laboratory; samples which were older than 2 h from collection were excluded. All haematological measurements were performed using an automated Advia 2120 (optical method) analyser by Siemens. The following PI were measured: PLT, MPV, plateletcrit (PCT) and PDW. Serum levels of C-reactive protein (CRP) were determined in fresh blood using latex-enhanced immunoturbidimetry.

Statistical analysis

Statistical analysis was carried out using Statistica 13 software. Power calculation was performed to estimate the required sample size. For a correlation of 0.1 between two variables, the required sample size was found to be 782, and for a correlation of 0.2, the required sample size was found to be 193 (with a power of 0.80 and alpha of 0.05). The data were verified for normality of distribution (Kolmogorov–Smirnov test) and equality of variances (Levene test). Mean ± standard deviation (SD) was used for continuous variables, while relative frequencies were used for categorical variables. The one-way analysis of variance (ANOVA), Mann–Whitney test, and Chi square test with Yates’ correction were used to compare the groups. Pearson product moment or Spearman correlation coefficients were used to assess the relationship between two quantitative variables. Multiple regression analysis was performed and partial correlations between PI and functional/cognitive assessment were calculated to control the effects of age, BMI and CRP. General linear models and logistic regression models were constructed to identify factors independently predicting functional and cognitive assessment variables with PI, age, sex, BMI, CRP and concomitant diseases, as independent variables. ADL (≤ 5 vs. 6) and IADL (≤ 7 vs. 8) values were dichotomised, while MMSE and CRP values were log transformed for the purpose of multivariate analyses. Values of p below 0.05 were considered statistically significant.

Results

The general, anthropometric and biochemical characteristics of the patients are presented in Table 1. Women predominated in the study group (71% women vs. 29% men) as did the old subgroup, as classified by the WHO (75–89 years old). The mean age of the participants was 80.69 ± 8.16 years, with men being almost 2 years older than women. Men had lower PLT and PCT but higher MPV.

Table 1 Basic characteristics of the study group

Table 2 presents the prevalence of selected concomitant disorders. Men were more likely to have atrial fibrillation and a history of myocardial infarction. Hypercholesterolemia, osteoporosis, osteoarthrosis and depression were more often reported in women (Table 2). Concomitant diseases were related to both PI and cognitive and physical assessment data. Patients with diabetes had higher MPV as compared to the subjects without diabetes (9.02 ± 1.09 vs. 8.67 ± 0.96; p < 0.001). Subjects with previous myocardial infarction had lower PLT (227.0 ± 80.2 vs. 259.0 ± 98.8; p = 0.005) and PCT (0.20 ± 0.06 vs. 0.22 ± 0.08; p = 0.04), with higher MPV (9.10 ± 1.07 vs. 8.71 ± 1.00; p = 0.01) and PDW (54.7 ± 7.5 vs. 52.9 ± 7.6; p = 0.04) as compared to the subjects without previous myocardial infarction. Chronic heart failure was associated with higher MPV (8.90 ± 1.09 vs. 8.63 ± 0.94; p < 0.001) and PDW (53.9 ± 7.8 vs. 52.5 ± 7.5; p = 0.009). Subjects with atrial fibrillation had higher PDW (55.3 ± 7.6 vs. 52.6 ± 7.6; p < 0.001) as compared to subjects without atrial fibrillation. Difference of PLT between patients with hypertension and healthy subjects was of borderline significance (252.1 ± 93.6 vs. 268.4 ± 109.6, respectively; p = 0.10), and hypertension was also included in the multivariate analysis. PI was not different between patients diagnosed with dementia and healthy peers.

Table 2 Prevalence of selected concomitant diseases

MMSE and CDT were lower in subjects with coronary heart disease, heart failure, atrial fibrillation, after stroke, with depression and dementia. ADL and IADL were lower in subjects with coronary heart disease, with heart failure, after stroke, with depression and dementia, and were higher in subjects with hypercholesterolemia. VES-13 was higher (worse) in subjects with coronary heart disease, after stroke, with heart failure, with depression and dementia.

In the whole studied population, PLT (r = − 0.12; p < 0.01) and PCT (r = − 0.12; p < 0.01) were inversely related to age and MPV was directly associated with BMI (r = 0.092; p < 0.05). In women, PCT (r = − 0.087; p < 0.05) was inversely related to age and MPV was directly associated with BMI (r = 0.12; p < 0.01). In men, the relationship of age to PCT was of borderline significance (r = − 0.13; p = 0.06). A direct positive correlation was found between PLT and CRP, and between PCT and CRP (Spearman’s r = 0.23, p < 0.001 and r = 0.25, p < 0.001, respectively). CRP was inversely associated with MMSE, CDT, ADL, IADL and directly to VES-13 with the highest correlation coefficient found between ADL and CRP (Spearman’s r = − 0.27, p < 0.001).

Our results also identified a strong positive correlation of MPV with PDW and a negative correlation between MPV and PLT. PDW was inversely correlated to PLT and PCT, with an obvious strong direct correlation between PLT and PCT. An applied antiplatelet pharmacotherapy involved aspirin (47%), ticlopidine (0.4%) and clopidogrel (3.5% of the subjects). Platelet indices were not related to the applied antiplatelet therapy (aspirin, ticlopidine and clopidogrel merged together for statistical analysis).

The relationship between platelet indices and functional and cognitive assessment

Spearman’s rank correlation coefficients between PI and cognition function (MMSE, CDT) were not statistically significant, neither in the whole study group nor in sex groups. A very weak negative correlation (p < 0.05) was revealed between PLT and PCT with ADL (r = − 0.087 and r = − 0.077), but these correlations became insignificant when subjected to sex-specific analyses. Observed correlations were quasi-identical when analysing per age categories: in subjects aged < 80 years (n = 288) and aged ≥ 80 years (n = 466) and in subjects aged < 85 years (n = 483) and ≥ 85 years (n = 271). Association of PI to functional and cognitive assessment data was similar in subjects with MMSE ≥ 11 (n = 728) and subjects with MMSE ≥ 24 (n = 482) as compared to the whole studied population. The only weak correlations of ADL to PLT and PCT with Spearman’s r ranging from − 0.089 to − 0.10 were found.

Table 3 presents partial correlations (partial r) between platelet indices and functional and cognitive assessment in the whole study group and according to sex after adjustment for age, BMI and CRP. Partial correlation coefficients between PI and cognition function (MMSE, CDT) were not statistically significant, neither in the whole study group nor in sex groups. A very weak negative correlation (p < 0.05) between PLT and PCT with ADL, and positive correlation between PLT and PCT with VES-13 was revealed, but these correlations became insignificant when subjected to sex-specific analyses. PDW was also inversely related to VES-13 in men (Table 3).

Table 3 Partial correlations (partial r) between platelet indices and functional and cognitive assessment in the whole study group and according to sex after adjustment for age, BMI and CRP

Multivariate analyses with adjustments for age, sex, BMI, CRP and concomitant diseases with significant relationship to PI or functional and cognitive assessment variables in bivariate associations have also been performed. From PI, only PLT emerged as independent predictor of ADL. Age, CRP, coronary heart disease and dementia were independent predictors of MMSE. CDT was determined by age, CRP, depression and dementia. PLT (with p = 0.013) together with age, CRP, history of previous stroke, depression and dementia were independent predictors of ADL. IADL was determined by age, CRP, history of previous stroke, depression and dementia. VES-13 was predicted by age, CRP, depression and dementia.

Discussion

The present study evaluates the relationship between basic PI and cognitive and functional performance in the largest population of older hospitalized patients studied so far. Observed sex-specific differences in PI data and relationship of PI to age and BMI are generally similar to that found in previous studies [25,26,27,28,29,30].

A number of studies published in recent decades suggest that platelet function in AD may be altered [31, 32]. This influence of platelet activation on pathophysiological process in AD has been suggested in many studies [5, 33,34,35,36]. AD patients were reported to have increased levels of MPV and decreased levels of PDW [37]. MPV was higher in patients with acute ischemic stroke as compared to age- and sex-matched controls [38]. MPV has been proposed to be a novel index for silent cerebral infarction regardless of classical cardiovascular risk factors [39]. In the present study, no correlation was found between PLT, MPV, PCT or PDW and MMSE or CDT score in a large population of hospitalized older adults. Previous data suggested the presence of differences in MPV and PDW in patients with AD as compared to those with mild cognitive impairment (MCI), as well as between MCI group and a group of healthy controls, with a strong positive correlation between MPV and MMSE (r = 0.576, p < 0.001) and PDW and MMSE (r = 0.465, p < 0.001) after adjusting for age, sex, and body mass index [17]. Additionally, a study evaluating the relationship between PI and type of dementia (VD or AD) identified a positive correlation between MPV, PDW and MMSE, and found a lower PDW in the AD group than the VD group [15]. Conflicting results were provided by Turkish researchers, who found that AD patients had higher mean MPV than control group without cognitive dysfunction [16, 19]. Our results concerning the lack of coincidence of PI and MMSE are consistent with those of Koçer et al. who found no difference in PI between outpatients with AD and healthy controls [18]. Likewise, Koç et al. reported that MPV did not differentiate AD patients with mild and moderate stage based on MMSE scoring [19].

There are relatively few studies published to date, which examine the relationship between PI and functional dependence [40,41,42]. Conflicting data are also available on the association of PI to prognosis in cancer patients or in patients with coronary artery disease [41,42,43]. There was no correlation between the severity of functional ability assessed by the Rankin scale and the MPV in patients with recent ischemic stroke [38]. Platelet morphology contributes to platelet reactivity, but those associations are complex and far from complete understanding [44]. Interestingly, our results identify a significant negative correlation between Katz’ Index with PLT and PCT and positive correlation between PLT and PCT with VES-13, although these effects are very weak and not evident in separate sex analyses. In addition, no relationship was found between the results of IADL and PI. Furthermore, in fully adjusted models, only PLT emerged as a weak independent predictor of ADL. All other cognitive and functional status measures were determined by age, CRP and concomitant diseases. Our study was carried out as a part of a comprehensive geriatric evaluation at a particular moment for the patient—at the beginning of hospitalization in the geriatric ward. De Gonzalo-Calvo et al. examined a group of 119 patients in a nursing home setting who were around 5 years older, more functionally dependent (the Katz ADL 2 ± 2 vs. 5 ± 1.5) but with fewer medical diagnoses (2 ± 1 vs. 3 ± 1.5); they also found no relationship between PI and the Katz or Barthel indices, but they found that low levels of PDW were associated with increased 1-year mortality [40]. Therefore, as observed in the present report, the negative association of VES-13 and PDW in men seems worth confirming in future studies.

The observed correlations between PI and ADL or VES-13 could be influenced by the high prevalence of patients with acute infection and inflammation. The infection-dependent changes in platelet properties are well described [45]. A strong direct positive correlation between PLT and CRP and between PCT and CRP was found in the present study, together with characteristic correlations between PI. These associations are already known as they accompany platelet activation [29, 46]. CRP was also an independent predictor of all cognitive and functional tests in multivariate analysis. Although we have adjusted for CRP in multivariate assessments, obtained data may be specific for multimorbid older population with frequent inflammation status.

Conclusions

Hospitalized adults aged 60 years and older demonstrated no associations between PI and cognitive screening test (MMSE and CDT). Significant but weak correlations were found between PI and the results of the functional dependence screening questionnaires, but only between the ADL and VES-13 with PLT and PCT. In addition, these correlations except one were not evident in fully adjusted multivariate models. These associations could be influenced by the high prevalence of patients with acute infection and inflammation and multiple coexisting diseases. Therefore, platelet indices are not consistently associated with the cognitive and functional performance of older patients admitted to the hospital ward.